Beta-adrenergic blockers, immunotherapy, and skin testing

There is sufficient medical evidence to adopt a cautious attitude toward the concomitant use of allergen immunotherapy and beta -blocking agents and skin testing patients receiving beta -blocking agents. The American Academy of Allergy and Immunology therefore recommends. 1. Physicians should be aware of the potential increased risk associated with concomitant administration of allergen immunotherapy and beta -blocking agents and should not, when this is possible, use these drugs and immunotherapy concomitantly.